Psychedelic therapy and postpartum depression: priorities and prospects
Therapeutic Advances in Psychopharmacology March 1, 2026 Guillaume Thuery, Frank Crossen, Daniel Mc Loone et al. 1 citation
Approximately 15% of pregnant women experience postpartum depression (PPD). Even with currently available antidepressant treatments, many women will continue to be impaired by symptoms. Psychedelic therapy offers a promising transdiagnostic therapeutic strategy for several mental health disorders, and early results from current trials suggest that serotonergic psychedelics may represent a...